Advertisement

Topics

Companies Related to "Relapsed Chronic Lymphocytic Leukemia Global Clinical Trials Review" [Most Relevant Company Matches] RSS

19:32 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Relapsed Chronic Lymphocytic Leukemia Global Clinical Trials Review" found in our extensive corporate database of over 50,000 company records.

Showing "Relapsed Chronic Lymphocytic Leukemia Global Clinical Trials Review" Companies 1–25 of 9,600+

Extremely Relevant

Verastem Oncology

Verastem, Inc. (Nasdaq:VSTM), operating as Verastem Oncology, is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients. Verastem Oncology is currently developing duvelisib, a dual inhibitor of PI3K-delta and PI3K-gamma, which has successfully met its primary endpoint i...


Biothera Pharmaceuticals Inc.

Biothera Pharmaceuticals is a privately held biotechnology company developing Imprime PGG, a first-in-class, mid-clinical stage cancer immunotherapy that orchestrates an integrated anti-cancer immune response in combination with checkpoint inhibitors and tumor-targeting and anti-angiogenesis monoclonal antibodies. Imprime PGG has been well-tolerated in tri...

MaxCyte, Inc

MaxCyte is a clinical-stage cell therapeutics company with a growing pipeline of proprietary and partnered drug candidates. Programs in development are based on MaxCyte's platform technology which breaks down the barriers to ex vivo cell loading and the manufacture of viral vectors. MaxCyte's pipeline includes one product in Phase I/II clinical trials for the treatment of Chronic Lymphocytic Leuke...


Update Pharma Inc.

Update Pharma Inc. is developing UPI-928, an agent developed in the 1980’s by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the National Cancer Institute. Despite an acceptable safety database of over 2,000 treated patients, over 70 peer reviewed clinical publications that demonstrated efficacy in leukemi...

Relevant

Callisto Pharmaceuticals, Inc.

Callisto Pharmaceuticals, Inc., is a publicly traded biotechnology company on the American Stock Exchange (AMEX:KAL) and Frankfurt Exchange (CA4). Callisto's primary focus is the clinical development of two drugs to treat cancer, L-Annamycin for relapsed leukemia and Atiprimod for relapsed multiple myeloma (MM) and bone resorption. L-Annamycin, a drug from the anthracycline family, earlier complet...

ILEX Oncology

Based in San Antonio, Texas, ILEX has a marketed product, Campath®, a treatment for patients with refractory chronic lymphocytic leukemia. ILEX is also advancing a robust pipeline of oncology product candidates. The pipeline comprises multiple technologies at all stages of clinical development, including a monoclonal antibody, apoptosis-inducing agents, cytotoxic compounds with novel mechanisms o...

Biothera Pharmaceuticals, Inc.

Biothera is a privately held biotechnology company developing Imprime PGG, a clinical stage immunotherapy drug that modulates key immune cells to orchestrate a coordinated immune response to cancer that involves both the innate and adaptive immune system. Proof of concept has been established from single-arm and randomized phase 2 studies in non-small cell...

Global Outsourcing Review

GOR (Global Outsourcing Review) is well established as the only true GLOBAL journal providing informative articles on pharmaceutical outsourcing. Each issue of GOR contains editorials focussing on drug discovery, clinical trials, CRO activity, EDC and CTM technology, business strategy, manufacturing & logistics. GOR highlights important moves at regulatory offices e.g FDA (USA), EMEA (EU), and M...

GRAYLINE CLINICAL DRUG TRIALS

Founded in 1986, Grayline Clinical Drug Trials is a full-service contract research site dedicated to providing clinical trials management and support to pharmaceutical companies for Phase I – IV clinical trials under FDA review. Today, Grayline is recognized as a premiere clinical trials research facility. The company and its staff bring to each clinical trial project a formidable body of experi...

Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar® (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigat...

Biothera Pharmaceutical Inc.

Biothera is a privately held biotechnology company developing Imprime PGG, a late clinical stage immunotherapeutic drug candidate that modulates key immune cells to recognize and kill cancer. Proof of concept has been established from single-arm and randomized Phase 2 studies in non-small cell lung cancer (NSCLC), colorectal cancer, and chronic lymp...

Center for Oncology Research and Treatment, P.A

At the Center for Oncology Research and Treatment (CORT), we will carefully review your medical history, diagnosis, and physiologic status. This comprehensive evaluation allows your CORT physician to tailor our treatment recommendations to your individual condition. We may recommend that you consider participation in one of the numerous clinical trials available at our Center. You can learn more a...

Medical Metrics, Inc.

Medical Metrics, Inc. (MMI) is an experienced provider of independent imaging core lab services for clinical trials of medical devices, drugs, and biologics. For more than 10 years, MMI has partnered with clinical trial sponsors to conduct comprehensive imaging evaluations of treatments for musculoskeletal, cardiovascular, and neurological disorders. Tr...

Verified Clinical Trials, LLC

Verified Clinical Trials (VCT) was developed by experts active in the clinical research community to proactively improve clinical research participant safety and data quality in clinical research trials. Verified Clinical Trials defines itself as the world's leader in the field of database registries in clinical trial research, and is the only clinical res...

Aspire IRB

Clinical trials are an essential part of life science companies efforts to improvehealthcare,” said Cathryn Guidry, CEO of Aspire IRB. “We are excited about thisopportunity to serve the life science industry on both coasts, meaning our clientsonly need to hire one independent review board to meet the needs of varioustime zones.” The union of these two organizations is the first of its kind i...

Genoptix

Genoptix has developed a breadth of services that focus on the challenges of each phase of patient management to help in effective diagnosis, optimal treatment decisions and monitoring of hematopoietic diseases. We partner with community-based hematologist/oncologists to help them deliver the best possible personalized medicine.Genoptix COMPASS™ (Comprehensive Assessment) Services A hematopathol...

SanBio, Inc.

SanBio is a regenerative medicine company with cell based products in various stages of research, development and clinical trials. Its proprietary cell based product, SB623, is beginning Stage 2b clinical trials for treatment of chronic stroke. SanBio also began Stage 2 clinical trials for treatment of traumatic brain injury in 2015. More information about...

Coronado Biosciences, Inc.

Coronado Biosciences, Inc. is a private, clinical stage company that is focused on the development of therapeutic products for the treatment of cancer. Coronado has three programs; cndo102 activated NK cells for the treatment of relapsed/refractory AML, cndo101, a 4th generation doxorubicin analogue for the treatment of women with breast cancer who have the CAP17 duplication, and C1, a pan Bcl-2 ...

Ancillare, LP

Ancillare is the only organization of its kind with a singular focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying ...

ClinicalStudyDataRequest.com

ClinicalStudyDataRequest.com is the industry leader in global clinical trial data transparency. Its multi-sponsor Request System provides a secure process for researchers to request access to global clinical trial data through a publicly available website. An Independent Review Panel and process overseen by the Wellcome Trust review data requests received ...

High Point Clinical Trials Center

High Point Clinical Trials Center is a leading clinical research unit focused on the conduct of early stage clinical pharmacology and POC Studies for biotechnology and pharmaceutical companies worldwide. The dedicated trials facility specializes in the execution of Phase I-III clinical trials.

Minnesota Applied Research Center

MARC is a fully equipped clinical research site able to provide a full range of research services. MARC staff are experienced at taking research ideas from conception to completion in a proficient, prompt and cost-effecitve manner. MARC provides consulting services for the design and conduct of clinical trials, the review and monitoring of ongoing trials, as well as the documentation and submiss...

Advarra

Advarra, headquartered in Columbia, MD, provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. Its robust regulatory expertise and innovative technology ensure the highest standards of research ...

Worldwide Clinical Trials

Accelerate Your Development Program with Pinpoint Therapeutic Focus and Complete Spectrum of Services Worldwide Clinical Trials is a global CRO that provides full-service drug development services to the pharmaceutical and biotechnology industries.   As one of the most innovative and scientifically-driven contract research organizations, we offer exceptionally strong clinical trial m...

AutoImmune Incorporated

AutoImmune Inc. is a biopharmaceutical company developing a new class of orally administered pharmaceutical productsfor the treatment of autoimmune and other cell-mediated inflammatory diseases and conditions. At the start of 1999 the Company was conducting clinical trials for the following products: Colloral(R), for the treatment of rheumatoid arthritis, and AI 502, for the treatment of chronic t...


More From BioPortfolio on "Relapsed Chronic Lymphocytic Leukemia Global Clinical Trials Review"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks